Abbott Laboratories (ABT) Total Debt (2009 - 2026)
Abbott Laboratories (ABT) posted Total Debt of $32.6 billion for Q2 2026, down 4.23% sequentially from $34.0 billion in Q1 2026, and up 142.67% YoY from $13.4 billion in Q2 2025.
Abbott Laboratories (ABT) Total Debt (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Total Debt for 18 years, with the latest figure at $32.6 billion in Q2 2026.
- Quarterly Total Debt rose 142.67% year-over-year to $32.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $32.6 billion (up 142.67% YoY) and the FY2025 annual result came in at $12.9 billion, down 17.25% from the prior year.
- Total Debt slipped to $32.6 billion in Q2 2026 per ABT's latest filing, from $34.0 billion in the prior quarter.
- Over five years, Total Debt peaked at $34.0 billion in Q1 2026 and troughed at $12.9 billion in Q4 2025.
- A 5-year average of $17.4 billion and a median of $15.7 billion in 2023 frame the typical range for Total Debt.
- The sharpest annual moves came in 2025 and 2026: Total Debt dropped 17.25% in 2025, then surged 157.11% in 2026.
- Over 5 years, Total Debt stood at $19.0 billion in 2022, then decreased by 17.16% to $15.8 billion in 2023, then fell by 0.85% to $15.6 billion in 2024, then retreated by 17.25% to $12.9 billion in 2025, then jumped by 152.21% to $32.6 billion in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $32.6 billion, $34.0 billion, and $12.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 32.61 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 14.94 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 27.96 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 12.62 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 10.10 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 8.68 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 1.89 Bn |
| 10 | Zimmer Biomet Holdings | 19.38 Bn | 18.97 Bn | 1.54 Bn | 7.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.61 Bn |
| Mar 31, 2026 | 34.05 Bn |
| Dec 31, 2025 | 12.93 Bn |
| Sep 30, 2025 | 12.94 Bn |
| Jun 30, 2025 | 13.44 Bn |
| Mar 31, 2025 | 13.24 Bn |
| Dec 31, 2024 | 15.63 Bn |
| Sep 30, 2024 | 14.98 Bn |
| Jun 30, 2024 | 14.75 Bn |
| Mar 31, 2024 | 14.59 Bn |
| Dec 31, 2023 | 15.76 Bn |
| Sep 30, 2023 | 15.53 Bn |
| Jun 30, 2023 | 16.85 Bn |
| Mar 31, 2023 | 16.90 Bn |
| Dec 31, 2022 | 19.02 Bn |
| Sep 30, 2022 | 16.41 Bn |
| Jun 30, 2022 | 16.76 Bn |
| Mar 31, 2022 | 17.09 Bn |
| Dec 31, 2021 | 18.80 Bn |
| Sep 30, 2021 | 18.20 Bn |